Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

BDTX Black Diamond Therapeutics Inc

3,24

0,02 (0,62%)

19 Okt 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Black Diamond Therapeutics (NASDAQ:BDTX)
Historical Stock Chart
Von Sep 2024 bis Okt 2024

Click Here for more Black Diamond Therapeutics Charts.

Black Diamond Therapeutics (NASDAQ:BDTX)
Historical Stock Chart
Von Okt 2023 bis Okt 2024

Click Here for more Black Diamond Therapeutics Charts.

News Black Diamond Therapeutics Inc

Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
Montag 7 Oktober 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 23 September 2024 (4 Wochen vor) • Edgar (US Regulatory)

Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations
Montag 23 September 2024 (4 Wochen vor) • GlobeNewswire Inc.

Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC
Sonntag 22 September 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 September 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 September 2024 (1 Monat vor) • Edgar (US Regulatory)

Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024
Samstag 14 September 2024 (1 Monat vor) • GlobeNewswire Inc.

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
Donnerstag 8 August 2024 (2 Monate vor) • GlobeNewswire Inc.

Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Dienstag 6 August 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 6 August 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 August 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mittwoch 10 Juli 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Black Diamond Therapeutics Inc News-Artikel

Financial Select Sector

Gold vs US Dollar

Deutsche Telekom

Health Care Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen